The Asia Pacific Blood Glucose Test Strip market is fundamentally impacted by the rising pervasiveness of diabetes across the locale. The surge in way of life related diseases and the reception of stationary ways of life add to the developing diabetic population, in this way helping the interest for blood glucose test strips.
The market elements are formed by the segment shift towards a maturing population. As nations in the Asia Pacific region witness an ascent in the old population, there is an equal expansion in the quantity of people inclined to diabetes. This segment pattern is a key market factor, driving the utilization of blood glucose test strips.
There is a developing inclination for painless or marginally intrusive glucose monitoring arrangements. This change in buyer inclination is affecting market patterns, with an expanded interest for elective observing techniques that offer comfort and lessen distress. Makers focusing in on such developments gain an upper hand in the Asia Pacific locale.
The Asia Pacific Blood Glucose Test Strip market is described by a cutthroat scene with a few vital participants. Industry union, organizations, and joint efforts among producers influence market elements. Consolidations and acquisitions add to the general market construction and impact the availability and valuing of blood glucose test strips.
Social variables and healthcare practices one of a kind to the Asia Pacific locale shape market patterns. Conventional convictions and practices connected with healthcare impact the acknowledgment and utilization of blood glucose observing gadgets. Understanding these social subtleties is fundamental for makers to modify their items and marketing procedures successfully.
Perceiving the different monetary scene of the Asia Pacific locale, market players are decisively focusing in on estimating methodologies. Offering reasonable blood glucose test strips guarantees openness for a more extensive population, particularly in arising economies. Organizations are additionally investigating associations and coordinated efforts with healthcare suppliers to make their items more generally available.
Report Attribute/Metric | Details |
---|---|
Growth Rate | Â Â 5.80% (2022-2030) |
Asia Pacific Blood Glucose Test Strip Market Size was valued at USD 2.03 Billion in 2023. The Global Asia Pacific Blood Glucose Test Strip industry is projected to grow from USD 2.14 Billion in 2024 to USD 3.17 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.98% during the forecast period (2024 - 2032). Diabetes a metabolic condition that occurs due to insufficient production of insulin. Blood glucose monitoring is a routine procedure for monitoring the glucose level. Blood glucose strip market is continuously growing in the Asia pacific region. These devices monitor the glucose level in the blood. Different types of strips are available in the market having impregnate of glucose oxidase, glucose dehydrogenase and other type of enzymes. When blood comes in the contact with this enzymes, they react with the glucose in the blood and indicates the blood glucose level. Advances and development in the technology has introduced the number of different devices in the market. The major driving factor for the Asia Pacific blood glucose test strip market is continuously increasing diabetes population. Diabetic population is constantly increasing and glucose level monitoring is an important part of diagnosis and treatment of diabetes. Patient with diseases, for instance, diabetes can now live longer and healthier life due to continuously monitoring of disease. Additionally, increasing awareness about preventive care of various diseases, rising obese population, and changing lifestyle boosting the growth of the Asia Pacific blood glucose test strip market. However, lack of accuracy and relatively high chances of false positive results may slow the growth of the Asia Pacific blood glucose test strip market.Figure- Asia Pacific blood glucose test strip market, by types
Source- World Health Organization (WHO, white paper, company presentation, annual report
Key Players Some of the major key players in the Asia Pacific blood glucose test strip market are F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), LifeScan, Inc. (US), i-SENS. Inc. (South Korea), AgaMatrix (US), TaiDoc Technology Corporation (Taiwan), BioSensors, Inc. (US), Universal Biosensors (Australia), Beijing Yicheng Electronic Co., Ltd (China), Hmd Biomedical (Taiwan), and B. Braun Melsungen Ag (Germany). Segmentation
On the basis of types, the Asia Pacific blood glucose test strip market is segmented into glucose oxidase, glucose dehydrogenase, and other.
On the basis of technology, the Asia Pacific blood glucose test strip market is segmented into wicking technology and channel technology.
On the basis of end user, the Asia Pacific blood glucose test strip market is categorised in hospital, clinic, homecare and others
Regional Analysis Asia Pacific blood glucose test strip market is segmented into Japan, China, India, Australia, Republic of Korea and Rest of Asia Pacific. It is the fastest growing region in the global blood glucose strip market. The diabetic population in Asia Pacific is increasing continuously, which is the major driver the market. According to the World Health Organization (WHO), total diabetic population of India and China in 2012 was 61 million and 90 million respectively. Moreover, increasing awareness among the people, increasing healthcare expenditure and rising obese population have fuelled the growth of the market. China and India are the two major contributor to the Asia Pacific glucose test strip market owing to the presence of huge diabetic population.
Market Assessment
Source: World Health Organization (WHO, white paper, company presentation, annual report
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)